Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

European Journal of Cancer

Volumn 37, Issue 4, 2001, Pages 486-491

  Fernebro, E ^a   Madsen, R R ^b   Ferno M ^a   Brunner N ^b   Bendahl, P O ^a   Christensen, I J ^b   Johnson, A ^c   Nilbert, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b FINSEN LABORATORY   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Prognostic marker; Rectal cancer; Soluble plasminogen activator receptor (suPAR)

Indexed keywords

EDETIC ACID; PLASMINOGEN ACTIVATOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECTUM CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CELL SURFACE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035086985     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00422-6     Document Type: Article

References (20)

1. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival
2. Mesorectal excision for rectal cancer
3. Improved survival with preoperative radiotherapy in resectable rectal cancer
4. Proteases as prognostic markers in cancer
5. The urokinase-type plasminogen activator system in cancer metastasis: A review
6. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer
7. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
8. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer
9. Urokinase receptor and colorectal cancer survival
10. ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients
11. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients
12. Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients
13. Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis
14. Urokinas-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
15. Soluble urokinase receptor released from human carcinoma cells: A plasma parameter for xenograft tumor studies
16. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
17. The intact urokinase receptor is required for efficient vitronectin binding: Receptor cleavage prevents ligand interaction
18. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells